These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38838424)

  • 1. Alterations of brain structural and functional connectivity networks topology and decoupling in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease.
    Ding S; Li X; Huang Z; Wang L; Shi Z; Cai J; Zheng H
    Mult Scler Relat Disord; 2024 Jul; 87():105699. PubMed ID: 38838424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of Myelin Oligodendrocyte Glycoprotein Antibody-Related Disease and Its Mimicking Acute Demyelinating Syndromes in Children Using MRI-Based Radiomics: From Lesion to Subject.
    Ding S; Zheng H; Wang L; Fan X; Yang X; Huang Z; Zhang X; Yan Z; Li X; Cai J
    Acad Radiol; 2024 May; 31(5):2085-2096. PubMed ID: 38007367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant white matter microstructure detected by automatic fiber quantification in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease.
    Ding S; Shi Z; Huang K; Fan X; Li X; Zheng H; Wang L; Yan Z; Cai J
    Mult Scler Relat Disord; 2024 Apr; 84():105483. PubMed ID: 38354445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive function in pediatric-onset relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
    Fabri TL; O'Mahony J; Fadda G; Gur RE; Gur RC; Yeh EA; Banwell BL; Till C
    Mult Scler Relat Disord; 2022 Mar; 59():103689. PubMed ID: 35183817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin-oligodendrocyte glycoprotein antibody-associated disease.
    Marignier R; Hacohen Y; Cobo-Calvo A; Pröbstel AK; Aktas O; Alexopoulos H; Amato MP; Asgari N; Banwell B; Bennett J; Brilot F; Capobianco M; Chitnis T; Ciccarelli O; Deiva K; De Sèze J; Fujihara K; Jacob A; Kim HJ; Kleiter I; Lassmann H; Leite MI; Linington C; Meinl E; Palace J; Paul F; Petzold A; Pittock S; Reindl M; Sato DK; Selmaj K; Siva A; Stankoff B; Tintore M; Traboulsee A; Waters P; Waubant E; Weinshenker B; Derfuss T; Vukusic S; Hemmer B
    Lancet Neurol; 2021 Sep; 20(9):762-772. PubMed ID: 34418402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Radiological Characteristics of Children and Adults With First-Attack Myelin Oligodendrocyte Glycoprotein Antibody Disease and Analysis of Risk Factors for Predicting the Severity at Disease Onset in Central China.
    Li Y; Xie H; Zhang J; Zhou Y; Jing L; Yao Y; Duan R; Jia Y
    Front Immunol; 2021; 12():752557. PubMed ID: 34975841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid eosinophils in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease.
    Kornbluh AB; Campano VM; Har C; Dwivedi P; Suslovic W; Sepeta L; Kahn I
    Mult Scler Relat Disord; 2024 May; 85():105526. PubMed ID: 38489945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS.
    Duan Y; Zhuo Z; Li H; Tian DC; Li Y; Yang L; Gao C; Zhang T; Zhang X; Shi FD; Barkhof F; Liu Y
    J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):709-716. PubMed ID: 33687975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum NfL and EGFR/NfL ratio mRNAs as biomarkers for phenotype and disease severity of myelin oligodendrocyte glycoprotein IgG-associated disease.
    Wang X; Qu Y; Fan J; Ren H
    Front Immunol; 2024; 15():1388734. PubMed ID: 38807603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disrupted gray matter connectome in vestibular migraine: a combined machine learning and individual-level morphological brain network analysis.
    Chen W; Zhao H; Feng Q; Xiong X; Ke J; Dai L; Hu C
    J Headache Pain; 2024 Oct; 25(1):177. PubMed ID: 39390381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E.U. paediatric MOG consortium consensus: Part 2 - Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
    Baumann M; Bartels F; Finke C; Adamsbaum C; Hacohen Y; Rostásy K;
    Eur J Paediatr Neurol; 2020 Nov; 29():14-21. PubMed ID: 33158737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management.
    Ambrosius W; Michalak S; Kozubski W; Kalinowska A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder Masquerading as Multiple Sclerosis: An Under-Recognized Entity?
    Zheng Y; Cai MT; Li EC; Fang W; Shen CH; Zhang YX
    Front Immunol; 2021; 12():671425. PubMed ID: 34220818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease.
    Kim H; Lee EJ; Kim S; Choi LK; Kim K; Kim HW; Kim KK; Lim YM
    Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32184342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the applicability of the 2023 international MOGAD panel criteria in real-world clinical settings.
    Rechtman A; Freidman-Korn T; Zveik O; Shweiki L; Hoichman G; Vaknin-Dembinsky A
    J Neurol; 2024 Aug; 271(8):5102-5108. PubMed ID: 38809270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and MRI phenotype of children with MOG antibodies.
    Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
    Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain structural and functional alterations in MOG antibody disease.
    Zhuo Z; Duan Y; Tian D; Wang X; Gao C; Ding J; Zheng F; Zhang T; Zhang X; Barkhof F; Shi FD; Liu Y
    Mult Scler; 2021 Aug; 27(9):1350-1363. PubMed ID: 33054621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies.
    Zhao-Fleming HH; Valencia Sanchez C; Sechi E; Inbarasu J; Wijdicks EF; Pittock SJ; Chen JJ; Wingerchuk DM; Weinshenker BG; Lopez-Chiriboga S; Dubey D; Tillema JM; Toledano M; Yadav H; Flanagan EP
    Neurology; 2021 Sep; 97(13):e1351-e1358. PubMed ID: 34389648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United Kingdom.
    Satukijchai C; Mariano R; Messina S; Sa M; Woodhall MR; Robertson NP; Ming L; Wassmer E; Kneen R; Huda S; Jacob A; Blain C; Halfpenny C; Hemingway C; O'Sullivan E; Hobart J; Fisniku LK; Martin R; Dopson R; Cooper SA; Williams V; Waters PJ; Ramdas S; Leite MI; Palace J
    JAMA Netw Open; 2022 Jan; 5(1):e2142780. PubMed ID: 35006246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoupling of Structural and Functional Connectivity in Hubs and Cognitive Impairment After Mild Traumatic Brain Injury.
    Wang S; Gan S; Yang X; Li T; Xiong F; Jia X; Sun Y; Liu J; Zhang M; Bai L
    Brain Connect; 2021 Nov; 11(9):745-758. PubMed ID: 33605188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.